Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Study Evaluating Safety and Efficacy of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in OAB Patients

Next Previous
Search
Trial Profile

Pilot Study Evaluating Safety and Efficacy of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in OAB Patients

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 04 Mar 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors UroGen Pharma

Most Recent Events

  • 29 Feb 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
  • 31 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Nov 2015, according to ClinicalTrials.gov record.
  • 31 Aug 2015 Planned End Date changed from 1 Aug 2015 to 1 Jun 2016 as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top